|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?|
|Chung-Feng Huang, Ming-Lung Yu|
|Clin Mol Hepatol. 2019;25(2):168-171. Published online 2019 February 11 DOI: https://doi.org/10.3350/cmh.2018.1014|
Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
Hepatocellular carcinoma and direct-acting antivirals: A never ending story?
Direct acting antivirals
Unexpected viral relapses in hepatitis C virus-infected patients diagnosed with hepatocellular carcinoma during treatment with direct-acting antivirals
Early Detection of Hepatocellular Carcinoma After Treatment With Direct-Acting Antivirals: Selection Bias or Biologically Plausible?
Direct-acting antivirals and recurrence of hepatocellular carcinoma
The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma
Hepatocellular Carcinoma Occurrence/Recurrence after Direct-Acting Antivirals for Hepatitis C in Egyptian Cohort: Single-Center Experience
P1-084: Risk of hepatocellular carcinoma recurrence in patients treated with direct acting antivirals in real world setting
Direct-acting antivirals and the risk of hepatocellular carcinoma: The end of a polemic?
|This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.|